Abstract：Most of the diagnosis of cognitive function-related diseases is mainly based on clinical manifestations and subjective scales, and there is a lack of reliable and reproducible objective indicators for the assessment of cognitive function changes related to various diseases. P300 provides a reliable and reproducible objective index for the assessment of cognitive function related to various diseases, and has important clinical significance for the early diagnosis and early identification of cognitive impairment in clinical diseases. This article reviews the application of P300 in diseases related to cognitive function changes, so as to facilitate early intervention, treatment and prevention of cognitive changes in various diseases, and improve the prognosis and long-term quality of life of patients。
肖李甜,罗海龙. 事件相关电位P300在认知障碍相关疾病的临床应用[J]. 中国校医, 2023, 37(12): 945-948.
XIAO Litian, LUO Hailong. Clinical application of event-related potential P300 in cognitive impairment-related diseases. Chinese Journal of School Doctor, 2023, 37(12): 945-948.
[1] Helfrich RF,Knight RT. Cognitive neurophysiology: event-relatedpotentials[J]. Handb Clin Neurol,2019(160):543-558. [2] Jiang S,Qu C,Wang F,et al. Using event-related potential P300 asan electrophysiological marker for differential diagnosis and topredict the progression of mild cognitive impairment: a meta-analysis[J]. Neurol Sci,2015,36(7):1105-1112. [3] Papadaniil CD,Kosmidou VE,Tsolaki A,et al. Cognitive MMN andP300 in mild cognitive impairment and alzheimer’s disease: a highdensity EEG-3D vector field tomography approach[J]. Brain Res,2016,1648(Pt A):425-433. [4] Kim NY,Wittenberg E,Nam CS. Behavioral and neural correlatesof executive function: interplay between inhibition and updatingprocesses[J]. Front Neurosci,2017(11):378. [5] Polich J. Updating P300:an integrative theory of P3a and P3b[J].Clin Neurophysiol,2007,118(10):2128-2148. [6] Lima NC,Kirov R,de Almondes KM. Impairment of executivefunctions due to sleep alterations: an integrative review on the useof P300[J]. Front Neurosci,2022(16):906492. [7] Petersen RC,Morris JC. Mild cognitive impairment as a clinicalentity and treatment target[J]. Arch Neurol,2005,62(7):1160-1163,1167. [8] Han SH,Jeong HB,Park KY,et al.P300 latency changes in patientswith mild cognitive impairment after taking choline alphoscerate:apreliminary study[J]. eNeurologicalSci,2018(11): 5-8. [9] Yaffe K,Petersen RC,Lindquist K,et al. Subtype of mild cognitiveimpairment and progression to dementia and death[J]. DementGeriatr Cogn Disord,2006,22(4):312-319. [10] Wright GM.Objective assessment in dementia:automated psycho-metric tests and the P3[J]. Neuroepidemiology,1990,9(4):208-215. [11] Medvidovic S,Titlic M,Maras-Simunic M. P300 evoked potentialin patients with mild cognitive impairment[J]. Acta Inform Med,2013,21(2):89-92. [12] Howe AS,Bani-Fatemi A,De Luca V. The clinical utility of theauditory P300 latency subcomponent event-related potential inpreclinical diagnosis of patients with mild cognitive impairmentand alzheimer’s disease[J]. Brain Cogn,2014(86):64-74. [13] Jervis BW,Bigan C,Besleaga M. New-onset alzheimer’s diseaseand normal subjects 100% separated statistically by P300 andICA[J]. Am J Alzheimers Dis Other Demen,2020(35):1311361787. [14] Golob EJ,Johnson JK,Starr A. Auditory event-related potentialsduring target detection are abnormal in mild cognitive impairment[J]. Clin Neurophysiol,2002,113(1):151-161. [15] Olichney J,Xia J,Church KJ,et al. Predictive power of cognitivebiomarkers in neurodegenerative disease drug development: utilityof the P300 event-related potential[J]. Neural Plast,2022(2022):2104880. [16] Aarsland D,Bronnick K,Larsen JP,et al. Cognitive impairment inincident, untreated parkinson disease: the Norwegian ParkWeststudy[J]. Neurology,2009,72(13):1121-1126. [17] Hely MA,Reid WG,Adena MA,et al. The Sydney multicenterstudy of parkinson’s disease: the inevitability of dementia at 20years[J]. Mov Disord,2008,23(6):837-844. [18] Silva LM,Souza MA,Nobrega AC.Delayed latencies of auditoryevoked potential P300 are associated with the severity of Parkin-son’s disease in older patients[J]. Arq Neuropsiquiatr,2014,72(4):296-300. [19] Tang H,Huang J,Nie K,et al. Cognitive profile of Parkinson’sdisease patients: a comparative study between early-onset andlate-onset Parkinson’s disease[J]. Int J Neurosci,2016,126(3):227-234. [20] Tokic K,Titlic M,Beganovic-Petrovic A,et al. P300 wave changesin patients with parkinson’s disease[J]. Med Arch,2016,70(6):453-456. [21] Fisher RS,van Emde BW,Blume W,et al. Epileptic seizures andepilepsy: definitions proposed by the International League AgainstEpilepsy (ILAE) and the International Bureau for Epilepsy (IBE)[J]. Epilepsia,2005,46(4):470-472. [22] Elger CE,Helmstaedter C,Kurthen M. Chronic epilepsy and cogni-tion[J]. Lancet Neurol,2004,3(11): 663-672. [23] Jensen FE. Epilepsy as a spectrum disorder:implications from nov-el clinical and basic neuroscience[J]. Epilepsia,2011,52(Suppl 1):1-6. [24] Hermann B,Seidenberg M. Epilepsy and cognition[J]. EpilepsyCurr,2007,7(1):1-6. [25] Gupta S,Prasad A,Singh R,et al.Auditory and visual P300 respo-nses in early cognitive assessment of children and adolescentswith epilepsy[J]. J Pediatr Neurosci,2020,15(1):9-14. [26] Chen RC,Tsai SY,Chang YC,et al. Seizure frequency affectsevent-related potentials (P300) in epilepsy[J]. J Clin Neurosci,2001,8(5):442-446. [27] Watanabe S,Hara K,Ohta K,et al. Aroma helps to preserveinformation processing resources of the brain in healthy subjectsbut not in temporal lobe epilepsy[J]. Seizure,2013,22(1):59-63. [28] Soysal A,Atakli D,Atay T,et al. Auditory event-related potentials(P300) in partial and generalized epileptic patients[J]. Seizure,1999,8(2):107-110. [29] Sowndhararajan K,Kim M,Deepa P,et al. Application of the P300event-related potential in the diagnosis of epilepsy disorder: areview[J]. Sci Pharm,2018,86(2):10. [30] Schwarzbold M,Diaz A,Martins ET,et al. Psychiatric disordersand traumatic brain injury[J]. Neuropsychiatr Dis Treat, 2008,4(4):797-816. [31] Hauger SL,Olafsen K,Schnakers C,et al. Cognitive event-relatedpotentials during the sub-acute phase of severe traumatic brain injuryand their relationship to outcome[J]. J Neurotrauma,2017,34(22):3124-3133. [32] Li H,Li N,Xing Y,et al. P300 as a potential indicator in theevaluation of neurocognitive disorders after traumatic brain injury[J]. Front Neurol,2021(12): 690792.
2023, Vol. 37 
